Using Integrative Therapies to Improve Patient-Reported Outcomes in Breast Cancer Survivors: A Living Evidence-Based Clinical Practice Guideline
- PMID: 40207746
- PMCID: PMC11984063
- DOI: 10.1111/jebm.70029
Using Integrative Therapies to Improve Patient-Reported Outcomes in Breast Cancer Survivors: A Living Evidence-Based Clinical Practice Guideline
Abstract
Aim: Breast cancer imposes a serious disease and economic burden on patients. This guideline aims to develop a living evidence-based clinical practice recommendations to guide the use of integrative therapies for the improvement of patient-reported outcomes (PROs) in breast cancer survivors.
Methods: We searched systematic reviews and meta-analyses or conducted de nova systematic reviews and meta-analyses to support the recommendations. The grading of recommendations, assessment, development, and evaluation approach was used to rate the certainty of evidence and the strength of recommendations.
Results: The guideline panel issued 17 recommendations: for alleviating anxiety, strong recommendations in favor of muscle relaxation training, yoga, acceptance and commitment therapy, cognitive behavioral therapy, psychological education, and Tai Chi in general breast cancer survivors; for alleviating depression, strong recommendations in favor of mindfulness therapy, cognitive behavioral therapy, group psychotherapy, muscle relaxation training, acceptanceand commitment therapy in general breast cancer survivors, and exercise intervention for patients received radiotherapy; for sleep quality, conditional recommendations for all therapies; for pain, strong recommendations in favor of exercise intervention for postoperative breast cancer survivors; for alleviating fatigue, strong recommendations in favor of mindfulness therapy and group psychotherapy in general breast cancer survivors; for improving the quality of life, strong recommendations in favor of mindfulness therapy in general breast cancer survivors, Baduanjin and exercise intervention for patients undergoing anticancer treatment.
Conclusion: This proposed guideline provides recommendations for improving the PROs of breast cancer survivors. We hope these recommendations can help support practicing physicians and other healthcare providers for breast cancer survivors.
Keywords: breast cancer survivors; clinical practice guideline; integrative therapies; patient‐reported outcomes.
© 2025 The Author(s). Journal of Evidence‐Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Sung H., Ferlay J., Siegel R. L., et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249. - PubMed
-
- Thun M. J., Linet M. S., Cerhan J. R., Haiman C. A., and Schottenfeld D., Cancer Epidemiology and Prevention (Oxford University Press, 2017).
-
- Lyman G. H., Greenlee H., Bohlke K., et al., “Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline,” Journal of Clinical Oncology 36, no. 25 (2018): 2647–2655. - PubMed
-
- CAM Definitions | About CAM | Health Information | OCCAM, https://cam.cancer.gov/health_information/cam_definitions.htm.
Publication types
MeSH terms
Grants and funding
- No.CI2021A05502/the Research on the Construction of an Ecological Chain of Evidence for the Integration of Advantageous Diseases in Chinese and Western Medicine
- No.XDZYJZC-002/the National Administration of Traditional Chinese Medicine International Cooperation Special Traditional Chinese Medicine Overseas Development and Promotion Base
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
